This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Durkin, M. M.
Right arrow Articles by Wheat, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Durkin, M. M.
Right arrow Articles by Wheat, L. J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, 09 1997, 2252-2255, Vol 35, No. 9
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Comparison of radioimmunoassay and enzyme-linked immunoassay methods for detection of Histoplasma capsulatum var. capsulatum antigen

MM Durkin, PA Connolly and LJ Wheat
Department of Medicine, Indiana University School of Medicine, Indianapolis 46262, USA. MDURKIN@MDEP.IUPUI.EDU

The purpose of this study was to compare the conventional radioimmunoassay (RIA) to an enzyme-linked immunoassay (EIA) for the measurement of Histoplasma antigen in banked urine specimens. A correlation between the two methods would allow the EIA to be used as a nonradioactive alternative to the established 125I RIA. The study used stored urine from patients diagnosed with histoplasmosis during an outbreak in Indianapolis which began in 1988. Control specimens from healthy adults, patients with other fungal infections, urinary tract infections, or nonfungal pneumonia were also tested. Both the RIA and EIA were run concurrently. The RIA system measured antigen levels of 0.4 to 27.0 RIA units, while the EIA measured antigen levels of 0.6 to 20.1 units. Both the EIA and RIA detected measurable antigen levels in urine from 50 of 56 patients (89%) with disseminated disease and 11 of 30 patients (37%) with self-limiting disease. One of 96 control specimens, from a patient with paracoccidioidomycosis, was positive with both systems. Antigen levels measured by EIA correlated well with those measured by the established RIA method (correlation coefficient, 0.974). The EIA is an acceptable alternative to the RIA for measuring Histoplasma antigen levels in urine specimens.


This article has been cited by other articles:

  • Guimaraes, A. J., Frases, S., Gomez, F. J., Zancope-Oliveira, R. M., Nosanchuk, J. D. (2009). Monoclonal Antibodies to Heat Shock Protein 60 Alter the Pathogenesis of Histoplasma capsulatum. Infect. Immun. 77: 1357-1367 [Abstract] [Full Text]  
  • Qualtieri, J., Stratton, C. W., Head, D. R., Tang, Y.-W. (2009). PCR Detection of Histoplasma capsulatum var. capsulatum in Whole Blood of a Renal Transplant Patient with Disseminated Histoplasmosis. Annals of Clinical & Laboratory Science 39: 409-412 [Abstract] [Full Text]  
  • Connolly, P. A., Durkin, M. M., LeMonte, A. M., Hackett, E. J., Wheat, L. J. (2007). Detection of Histoplasma Antigen by a Quantitative Enzyme Immunoassay. CVI 14: 1587-1591 [Abstract] [Full Text]  
  • Wheat, L. J., Lindsley, M. D., Holland, H. L., Bragg, S. L., Hurst, S. F., Wannemuehler, K. A., Morrison, C. J. (2007). Evaluation of Reagents for Detection of Histoplasma capsulatum Antigenuria. CVI 14: 1387-1388 [Full Text]  
  • LeMonte, A., Egan, L., Connolly, P., Durkin, M., Wheat, L. J. (2007). Evaluation of the IMMY ALPHA Histoplasma Antigen Enzyme Immunoassay for Diagnosis of Histoplasmosis Marked by Antigenuria. CVI 14: 802-803 [Abstract] [Full Text]  
  • Lindsley, M. D., Holland, H. L., Bragg, S. L., Hurst, S. F., Wannemuehler, K. A., Morrison, C. J. (2007). Production and Evaluation of Reagents for Detection of Histoplasma capsulatum Antigenuria by Enzyme Immunoassay. CVI 14: 700-709 [Abstract] [Full Text]  
  • Kauffman, C. A. (2007). Histoplasmosis: a Clinical and Laboratory Update. Clin. Microbiol. Rev. 20: 115-132 [Abstract] [Full Text]  
  • Durkin, M., Witt, J., LeMonte, A., Wheat, B., Connolly, P. (2004). Antigen Assay with the Potential To Aid in Diagnosis of Blastomycosis. J. Clin. Microbiol. 42: 4873-4875 [Abstract] [Full Text]  
  • LYON, G. M., BRAVO, A. V., ESPINO, A., LINDSLEY, M. D., GUTIERREZ, R. E., RODRIGUEZ, I., CORELLA, A., CARRILLO, F., MCNEIL, M. M., WARNOCK, D. W., HAJJEH, R. A. (2004). HISTOPLASMOSIS ASSOCIATED WITH EXPLORING A BAT-INHABITED CAVE IN COSTA RICA, 1998-1999. Am J Trop Med Hyg 70: 438-442 [Abstract] [Full Text]  
  • Johnson, P. C., Wheat, L. J., Cloud, G. A., Goldman, M., Lancaster, D., Bamberger, D. M., Powderly, W. G., Hafner, R., Kauffman, C. A., Dismukes, W. E., for the U.S. National Institute of Allergy and Inf, (2002). Safety and Efficacy of Liposomal Amphotericin B Compared with Conventional Amphotericin B for Induction Therapy of Histoplasmosis in Patients with AIDS. ANN INTERN MED 137: 105-109 [Abstract] [Full Text]  
  • Yeo, S. F., Wong, B. (2002). Current Status of Nonculture Methods for Diagnosis of Invasive Fungal Infections. Clin. Microbiol. Rev. 15: 465-484 [Abstract] [Full Text]  
  • Wheat, L. J., Connolly, P., Haddad, N., Le Monte, A., Brizendine, E., Hafner, R. (2002). Antigen Clearance during Treatment of Disseminated Histoplasmosis with Itraconazole versus Fluconazole in Patients with AIDS. Antimicrob. Agents Chemother. 46: 248-250 [Abstract] [Full Text]  
  • Wheat, L. J., Cloud, G., Johnson, P. C., Connolly, P., Goldman, M., Le Monte, A., Fuller, D. E., Davis, T. E., Hafner, R., The AIDS Clinical Trials Group, , The Mycoses Study Group Of NIAID, (2001). Clearance of Fungal Burden during Treatment of Disseminated Histoplasmosis with Liposomal Amphotericin B versus Itraconazole. Antimicrob. Agents Chemother. 45: 2354-2357 [Abstract] [Full Text]  
  • Connolly, P., Wheat, L. J., Schnizlein-Bick, C., Durkin, M., Kohler, S., Smedema, M., Goldberg, J., Brizendine, E., Loebenberg, D. (2000). Comparison of a New Triazole, Posaconazole, with Itraconazole and Amphotericin B for Treatment of Histoplasmosis following Pulmonary Challenge in Immunocompromised Mice. Antimicrob. Agents Chemother. 44: 2604-2608 [Abstract] [Full Text]  
  • Garringer, T. O., Wheat, L. J., Brizendine, E. J. (2000). Comparison of an Established Antibody Sandwich Method with an Inhibition Method of Histoplasma capsulatum Antigen Detection. J. Clin. Microbiol. 38: 2909-2913 [Abstract] [Full Text]  
  • Kohler, S., Wheat, L. J., Connolly, P., Schnizlein-Bick, C., Durkin, M., Smedema, M., Goldberg, J., Brizendine, E. (2000). Comparison of the Echinocandin Caspofungin with Amphotericin B for Treatment of Histoplasmosis following Pulmonary Challenge in a Murine Model. Antimicrob. Agents Chemother. 44: 1850-1854 [Abstract] [Full Text]  
  • Goldberg, J., Connolly, P., Schnizlein-Bick, C., Durkin, M., Kohler, S., Smedema, M., Brizendine, E., Hector, R., Wheat, J. (2000). Comparison of Nikkomycin Z with Amphotericin B and Itraconazole for Treatment of Histoplasmosis in a Murine Model. Antimicrob. Agents Chemother. 44: 1624-1629 [Abstract] [Full Text]  
  • Connolly, P., Wheat, J., Schnizlein-Bick, C., Durkin, M., Kohler, S., Smedema, M., Goldberg, J., Brizendine, E., Loebenberg, D. (1999). Comparison of a New Triazole Antifungal Agent, Schering 56592, with Itraconazole and Amphotericin B for Treatment of Histoplasmosis in Immunocompetent Mice. Antimicrob. Agents Chemother. 43: 322-328 [Abstract] [Full Text]  
  • Pizzini, C. V., Zancope-Oliveira, R. M., Reiss, E., Hajjeh, R., Kaufman, L., Peralta, J. M. (1999). Evaluation of a Western Blot Test in an Outbreak of Acute Pulmonary Histoplasmosis. CVI 6: 20-23 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»